-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on TrueBlue, Raises Price Target to $8

Benzinga·08/06/2025 14:20:15
Listen to the news
BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and raises the price target from $7 to $8.